Organometallic chemistry and biochemistry have been merged in the last two decades into a new field: bioorganometallic chemistry. This new research area was devoted to the synthesis of new organometallic compounds and their biological and medical effects against some types of diseases, such as cancer and malaria. For several years, the use of ferrocene in bioorganometallic chemistry has been growing rapidly, and several promising applications have been developed since ferrocene is a stable, nontoxic compound and has good redox properties. This review will focus on ferrocenyl compounds which have been biologically evaluated against certain diseases. This area has attracted many researchers due to the promising results of some ferrocene compounds in the medicinal applications.

No abstract

Quantum dots (QDs) are nanocrystals of a semiconductor material that exist in a size regime less than 10 nm. QDs have become promising nanoparticles for a wide variety of different applications. However, the major drawback of QDs is their potential toxicity. This review reports on some recent methods for the synthesis of QDs and explores their properties, structures, applications, and toxicity. QDs are extraordinary because their minute size produces a physically confined electron cloud, an effect known as the quantum confinement. Certainly, because of their special properties as they had a great unique optical, electronic, and chemical properties that were not observe in other materials. These unique properties of the QD are an attractive material for a variety of scientific and commercial applications, most of them recently been realized, such as biosensors, bioimaging, photodetectors, displays, solar cells, wastewater treatment, and quantum computers. Finally, but not the end, an interesting potential QD application in future perspectives will expect as light-emitting diode products, biomedical applications, and Li-Fi.

A ferrocenyl ligand was prepared from condensation of l,l′-diacetylferrocene with 2-amino-5-methylthiazole, to give the ligand. This ligand forms 1:1 complexes with lead(II), cobalt(II), nickel(II), copper(II) and zinc(II) in good yield. Characterization of the ligand and complexes was carried out using IR, NMR, electronic absorption, magnetic susceptibility, molar conductivity and elemental analysis. Anticancer activity of the prepared ligand and its complexes against breast cancer cell line MCF-7 was determined. The anticancer activity of the new complexes was accompanied by significant increase in the activity of superoxide dismutase, with a parallel decrease in the activities of catalase and glutathione peroxidase and reduced glutathione level. Accordingly, the overproduction of free radicals allowed reactive oxygen species-mediated cancer cell death. The results suggest that the complexes possess significant anticancer activity comparable to cisplatin.

A new series of Schiff bases containing benzіmidazole moiety 11-17 were synthesized by the reaction of 4-(1H-benzо[d]іmіdazоl-2-yl)anіline (1) with different aromatic aldehydes (4-10) via conventional heating and microwave irradiation methods. The structures of the novel Schiff bases were characterized by using different spectral data. Also, metal complexes 18-21 of compound 13 were synthesized, and their structure was confirmed by spectral measurements (IR, NMR, UV), molar conductivity, magnetic susceptibility and thermo-gravimetric analysis. The novel synthesized ligand 13 and its complexes 18-21 were tested for their in vitro antitumor activities towards breast, liver and lung cancer cell lines. Also, the acute toxicity of the prepared compounds 13 and 18-21 was determined in vivo. The results showed that the newly synthesized compounds 13 and 18-21 exhibited a significant activity against cancer, especially for complex 21, compared to standard drug doxorubicin. The molecular docking of complexes 20 and 21 has been also studied as Aurora kinase inhibitors.